1. Home
  2. IDN vs INKT Comparison

IDN vs INKT Comparison

Compare IDN & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intellicheck Inc.

IDN

Intellicheck Inc.

HOLD

Current Price

$4.16

Market Cap

87.5M

Sector

Technology

ML Signal

HOLD

Logo MiNK Therapeutics Inc.

INKT

MiNK Therapeutics Inc.

HOLD

Current Price

$11.46

Market Cap

70.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDN
INKT
Founded
1994
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
87.5M
70.6M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
IDN
INKT
Price
$4.16
$11.46
Analyst Decision
Strong Buy
Buy
Analyst Count
3
2
Target Price
$7.33
$35.00
AVG Volume (30 Days)
393.7K
22.5K
Earning Date
05-12-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
220.00
N/A
EPS
0.03
N/A
Revenue
$4,433,454.00
N/A
Revenue This Year
$12.54
N/A
Revenue Next Year
$15.32
N/A
P/E Ratio
$138.00
N/A
Revenue Growth
23.21
N/A
52 Week Low
$3.95
$7.01
52 Week High
$9.08
$76.00

Technical Indicators

Market Signals
Indicator
IDN
INKT
Relative Strength Index (RSI) 40.11 48.82
Support Level $3.99 $10.82
Resistance Level $5.07 $12.61
Average True Range (ATR) 0.19 0.66
MACD 0.09 -0.09
Stochastic Oscillator 33.33 35.19

Price Performance

Historical Comparison
IDN
INKT

About IDN Intellicheck Inc.

Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company includes solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells, and suppress graft-versus-host-disease. Its product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy. It operates its business in single segment.

Share on Social Networks: